ESC Premium Access

Impact of low-surgical-risk TAVI trials on clinical decision making

Event: ESC CONGRESS 2019
Topic: Diseases of the Aorta
Session type: Satellite Symposium
Sponsored by Medscape Education Global
Date: 1 September 2019
Time: 18:15 - 19:00

Session

6 presentations in this session

Welcome and introductions

Speaker: Professor L. Pierard (Liege, BE)
Thumbnail

Asymptomatic patients at risk with severe aortic stenosis

Speaker: Professor L. Pierard (Liege, BE)
Thumbnail

Clinical case - A low surgical risk patient undergoing TAVI

Speaker: Professor T. Modine (Lille, FR)
Thumbnail

Do valve hemodynamic function and durability matter?

Speaker: Professor P. Pibarot (Quebec, CA)
Thumbnail

What is the impact on clinical practice of low-risk TAVI trials?

Speaker: Associate Professor G. Tarantini (Padua, IT)
Thumbnail

Questions and answers and panel discussion

Speaker: Professor L. Pierard (Liege, BE)
Thumbnail

6 speakers from this session

Professor Luc Pierard

University of Liege, Liege (Belgium)
15 presentations
0 follower

Professor Luc Pierard

University of Liege, Liege (Belgium)
15 presentations
0 follower

Professor Thomas Modine

CHRU Lille, Lille (France)
5 presentations
0 follower

Professor Philippe Pibarot

Quebec Heart and Lung Institute, Quebec (Canada)
25 presentations
0 follower

Associate Professor Giuseppe Tarantini

University Hospital of Padova, Padua (Italy)
8 presentations
1 follower

Professor Luc Pierard

University of Liege, Liege (Belgium)
15 presentations
0 follower

This platform is supported by

logo Novo Nordisk